Evidence map›Paper›PMID 26045285›Full record

ReviewMycopathologia2015

Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.

H B Liu, F Liu, Q T Kong, Y N Shen, G X Lv, W D Liu, H Sang

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Molecular Epidemiology and Antifungal Susceptibility ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  3. Majocchi granuloma presenting as a verrucous nodule of the lip.Proceedings (Baylor University. Medical Center) · 2018
    Article
  4. Majocchi's granuloma: current perspectives.Infection and drug resistance · 2018
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

H B LiuJinling Hospital, Department of Dermatology, Nanjing University, School of Medicine, Nanjing, 210002, People's Republic of China.
F Liu
Q T Kong
Y N Shen
G X Lv
W D Liu
H Sang
Nanjing General Hospital of Nanjing Military Command · CNPeking Union Medical College Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Majocchi's granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsCeftizoximeCoinfectionGranulomaHumansKlebsiella InfectionsKlebsiella pneumoniaeLevofloxacinMaleMiddle AgedTineaTreatment OutcomeTrichophytonVoriconazoleAnti-Bacterial AgentsAntifungal AgentscefoselisCeftizoximeLevofloxacinVoriconazole

Identifiers

PMID26045285
OpenAlexW567525248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.